Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Exclusion Criteria

• •1. Women who are nursing or pregnant during the study period;
• •2. Patients with carcinoid tumors, small-cell carcinoma of the lung;
• •3. A history of another malignancy within the last five years (except for cured basal cell carcinoma of the skin and cured carcinoma in situ of the uterine cervix);
• •4. Any other morbidity or situation with contraindications for chemotherapy (e.g. active infection, myocardial infarction in the preceding 6 months);
• •5. Neutrophil counts \< 1,500 cells/mm3;
• •6. A history of hypersensitivity to docetaxel or cisplatin;
• •7. Symptomatic heart disease including unstable angina, congestive heart failure or uncontrolled arrhythmias;
• •8. Subjects have active hepatitis;
• •9. Subjects are known positive for Human Immunodeficiency Virus (HIV);
• •10. Any condition judged by investigator, participates the study will jeopardize patient's wellbeing